DPYD and dihydropyrimidine dehydrogenase deficiency: As laboratories adopt next-generation sequencing, their ability to detect rare copy number variants (CNVs) in the DPYD gene will improve, helping to explain cases of DPD deficiency or 5-FU toxicity [9].